Skip to content
Search

Latest Stories

17 more added to December price concessions

Pb Staff writer
By Pb Staff writerDec 18, 2020
Pb Staff writer
See Full Bio

The Department of Health and Social Care on Friday (December 18) included 17 drugs in its second price concessions list for December 2020.

DrugPack SizePrice Concession
Ciprofloxacin 500mg tablets10£3.30
Desmopressin 10micrograms/dose nasal spray60 dose£22.81
Docusate 12.5mg/5ml oral solution sugar free300ml£13.19
Docusate 50mg/5ml oral solution sugar free300ml£13.39
Docusate 100mg capsules30£3.20
Entacapone 200mg tablets30£8.12
Eplerenone 25mg tablets28£8.20
Eplerenone 50mg tablets28£7.79
Esomeprazole 40mg gastro-resistant capsules28£3.01
Esomeprazole 20mg gastro-resistant tablets28£5.58
Lamotrigine 200mg tablets56£5.08
Olmesartan medoxomil 10mg tablets28£3.09
Olmesartan medoxomil 40mg tablets28£3.79
Sulfasalazine 500mg gastro-resistant tablets112£11.95
Sulfasalazine 500mg tablets112£7.20
Trimethoprim 100mg tablets28£2.07
Zonisamide 100mg capsules56£61.16

Previous drug price concessions list released for December 2020.

DrugPack SizePrice Concession
Ciprofloxacin 250mg tablets10£1.50
Duloxetine 20mg gastro-resistant capsules28£8.48
Duloxetine 30mg gastro-resistant capsules28£1.90
Duloxetine 40mg gastro-resistant capsules56£13.69
Duloxetine 60mg gastro-resistant capsules28£3.99
Enalapril 10mg tablets28£5.50
Enalapril 20mg tablets28£9.63
Hydrocortisone 2.5% cream15g£44.00
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets28£14.31
Lamotrigine 100mg tablets56£6.50
Lamotrigine 25mg tablets56£1.95
Lamotrigine 50mg tablets56£3.99
Moxonidine 200microgram tablets28£8.52
Moxonidine 300microgram tablets28£8.22
Moxonidine 400microgram tablets28£7.30
Olanzapine 10mg tablets28£2.75
Olanzapine 15mg tablets28£3.84
Olanzapine 20mg tablets28£4.60
Prochlorperazine 5mg tablets28£1.30
Rasagiline 1mg tablets28£7.20
Senna 7.5mg tablets60£2.50
Tamoxifen 20mg tablets30£10.50

Related News

Operation Subaru:
News

12 arrested in MHRA’s biggest medicines trafficking crackdown

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair
News

Olivier Picard named new NPA chair

RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care
News

Professor Tony Avery OBE awarded RPS Honorary Fellowship

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.
News

Pharma sector needs protecting from Trump tariffs, warn MPs

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc